RecruitingNCT06529614
An In-situ Detection for MicroRNA
A New Detection Method for MicroRNA in Patients With Breast Cancer
Sponsor
Tongji Hospital
Enrollment
100 participants
Start Date
Jul 20, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 75 Years
Inclusion Criteria1
- \-
Exclusion Criteria1
- situations that may affect the results
Interventions
OTHERIn-situ detection for Micro-RNA
a new in-situ detection methods for Micro-RNA
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06529614
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
NCT052915071 location